November 18, 2024 —

The American College of Rheumatology (ACR) released a summary of the 2024 ACR Guideline for the Screening, Treatment, and Management of Lupus Nephritis during ACR Convergence 2024. “This is the College’s first lupus nephritis guideline since 2012 and provides evidence-based, expert guidance for the condition in adults and children.”

Lupus Therapeutics, clinical affiliate of the Lupus Research Alliance, caught up with Dr. Maria Dall’Era after her presentation on the new American College of Rheumatology guidelines in lupus nephritis. Watch the interview.

Dr. Dall’Era serves as Chair of the Lupus Clinical Investigators Network, a network that Lupus Therapeutics oversees of premier clinical research institutions in North America, to help progress clinical trials forward faster for sponsors/investigators, ensure individuals enrolled receive the best overall care and lead studies to achieve the best outcomes.

Source: ACR Press Release Nov. 18, 2024